GenieUs Genomics, Duke and Temple Universities - Tackle ALS Heterogeneity with Genomic Profiling in New Clinical Trial
GenieUs Genomics (GenieUs), in collaboration with Duke University and Temple University, is launching the first-ever precision health approach to patient stratification in a clinical research study for amyotrophic lateral sclerosis (ALS) in the United States.